Table 3.
Indications for LAA closure | n = 45 |
---|---|
CHADS2 score | 3.1 ± 1.3 |
CHADS-VASc score | 4.9 ± 1.6 |
HASBLED score | 4.2 ± 1.0 |
Previous major bleeding | 42 (93.3%) |
Intracranial bleed | 17 (37.8%) |
Intraocular bleed | 2 (4.4%) |
Gastrointestinal bleed | 21 (46.7%) |
Retroperitoneal bleed | 3 (6.7%) |
Genitourinary bleed | 1 (2.2%) |
Transfusions | 22 (48.9%) |
High fall risk (seizure) | 1 (2.2%) |
Other reasons: oesophageal varices, non-healing venous ulcers | 2 (4.4%) |
Baseline antithrombotic | |
None | 16 (35.6%) |
Aspirin | 16 (35.6%) |
Clopidogrel | 3 (6.7%) |
Aspirin + clopidogrel | 1 (2.2%) |
Warfarin | 7 (15.6%) |
Novel OAC | 2 (4.4%) |
Heparin | 2 (4.4%) |